61
Views
9
CrossRef citations to date
0
Altmetric
Original Research

The impact of indacaterol/glycopyrronium fixed-dose combination versus tiotropium monotherapy on lung function and treatment preference: a randomized crossover study – the FAVOR study

&
Pages 69-77 | Published online: 22 Dec 2017

References

  • TashkinDPLong-acting anticholinergic use in chronic obstructive pulmonary disease: efficacy and safetyCurr Opin Pulm Med20101629710520019615
  • World Health OrganizationThe top 10 causes of death. [webpage on the Internet] Available from: http://www.who.int/mediacentre/factsheets/fs310/en/Accessed August 17, 2017
  • KardosPVogelmeierCBuhlRCrieeCPWorthHThe Prospective Non-Interventional DACCORD Study in the National COPD Registry in Germany: design and methodsBMC Pulm Med2015151225578330
  • TashkinDPFergusonGTCombination bronchodilator therapy in the management of chronic obstructive pulmonary diseaseRespir Res20131414923651244
  • GOLDGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease2016 Available from: www.goldcopd.orgAccessed August 17, 2017
  • CazzolaMPageCLong-acting bronchodilators in COPD: where are we now and where are we going?Breathe2014102110120
  • BatemanEDFergusonGTBarnesNDual bronchodilation with QVA149 versus single bronchodilator therapy: the SHINE studyEur Respir J20134261484149423722616
  • WedzichaJADecramerMFickerJHAnalysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group studyLancet Respir Med20131319920924429126
  • MahlerDAKerwinEAyersTFLIGHT1 and FLIGHT2: efficacy and safety of QVA149 (indacaterol/glycopyrrolate) versus its mono-components and placebo in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med201519291068107926177074
  • DahlRChapmanKRRudolfMSafety and efficacy of dual bronchodilation with QVA149 in COPD patients: the ENLIGHTEN studyRespir Med2013107101558156723867808
  • GOLDGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease2013 Available from: www.goldcopd.orgAccessed August 17, 2017w
  • RestrepoRDAlvarezMTWittnebelLDMedication adherence issues in patients treated for COPDInt J Chron Obstruct Pulmon Dis20083337138418990964
  • BharmalMPayneKAtkinsonMJDesrosiersMPMoriskyDEGemmenEValidation of an abbreviated Treatment Satisfaction Questionnaire for Medication (TSQM-9) among patients on antihypertensive medicationsH Health Qual Life Outcomes20097136
  • JonesPWDonohueJFNedelmanJPascoeSPinaultGLassenCCorrelating changes in lung function with patient outcomes in chronic obstructive pulmonary disease: a pooled analysisRespir Res201112116122206353
  • DonohueJFJonesPBartelsCRelationship between change in trough FEV1 and COPD patient outcomes: pooled analysis of 23 clinical trials in patients with COPDEur Respir Soc201546A1013
  • RevickiDAPatient assessment of treatment satisfaction: methods and practical issuesGut20045344044
  • RuizMAPardoARejasJSotoJVillasanteFArangurenJLDevelopment and validation of the “Treatment Satisfaction with Medicines Questionnaire” (SATMED-Q)Value Health200811591392618494753